CIDRAP newsletters options
A randomized controlled trial of hospitalized COVID-19 patients in Brazil found that the use of hydroxychloroquine, with or without azithromycin, did not improve clinical status at 15 days compared with standard care, researchers reported today in the New England Journal of Medicine.
A 2019 survey of clinical commissioning groups in England showed an increase in antimicrobial stewardship (AMS) programs compared with the previous survey, according to a report yesterday from UK nonprofit The Patients Association.
Dr. Osterholm clarifies that he supports the wearing of cloth face coverings in public and urges people to stop citing CIDRAP and him as grounds for not wearing masks, but he also asks that advocates not use poorly conducted studies to support their use.
In the past day, the US, Brazil, and India reported more than 143,000 new cases combined.
Antibody levels dropped by about half every 73 days—not good news for vaccine prospects.
For the first time in more than a month, daily US deaths top 1,000.
Two more Ebola infections were confirmed in the Democratic Republic of the Congo (DRC) Equateur province outbreak, both of them in Mbandaka, the provincial capital, the World Health Organization (WHO) African regional office and its DRC office said on Twitter.
Early in the COVID-19 pandemic, US emergency department (ED) physicians said they were stressed by exposures to infected patients to the point that it impinged on their home lives and female ED doctors reported higher stress levels than their male counterparts, according to survey results published today in Academic Emergency Medicine.
Data show that at least 10 times more people were probably infected than previously reported.
The report highlights data inconsistencies and lack of federal leadership.
Health officials see no let-up in the surge of COVID-19 cases in the Americas.
A phase 3 clinical trial involving 531 people living along the China-Myanmar border has shown that the antimalarial-antibacterial drug combination naphthoquine-azithromycin (NQAZ) is effective in preventing malarial Plasmodium infections.
Of the 3,334 consecutive patients hospitalized with COVID-19 at a New York City hospital, 553 (16%) had thrombosis (blood clots), according to a research letter published yesterday in JAMA.
The vaccines prompt an immune response and appear to be safe.
The weekly average for new daily US cases climbs for the 41st day in a row.
Three more Ebola infections were confirmed in the Democratic Republic of the Congo (DRC) Equateur province over the weekend, raising the total to 60 cases, the World Health Organization (WHO) African regional office said on Twitter today. Of the total, 56 are confirmed and 4 are listed as probable.
Two more deaths were reported, raising the total to 24.
The official COVID-19 death count from the pandemic in Italy is likely a significant undercount, according to a research letter published today in JAMA Internal Medicine.
Data from a large randomized controlled trial in the UK show a benefit from dexamethasone in hospitalized COVID-19 patients, but 2 more studies show no benefit for hydroxychloroquine.
Hospitals in Georgia and Arizona are looking to nearby states to take on patients.
Brazil tops 2 million cases and India 1 million as the UN appeals for aid for hard-hit countries.
